<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Basic Med Sci</journal-id><journal-title-group><journal-title>Iranian Journal of Basic Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2008-3866</issn><issn pub-type="epub">2008-3874</issn><publisher><publisher-name>Mashhad University of Medical Sciences</publisher-name><publisher-loc>Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5569441</article-id><article-id pub-id-type="publisher-id">IJBMS-20-708</article-id><article-id pub-id-type="doi">10.22038/IJBMS.2017.8841</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Repeated systemic administration of the cinnamon essential oil possesses anti-anxiety and anti-depressant activities in mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sohrabi</surname><given-names>Reyhaneh</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pazgoohan</surname><given-names>Nasim</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Seresht</surname><given-names>Hasan Rezaei</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Amin</surname><given-names>Bahareh</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran</aff><aff id="aff2"><label>2</label>Traditional and Complementary Medicine Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran</aff><aff id="aff3"><label>3</label>Cellular and Molecular Research Center, Department of Physiology and Pharmacology, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran</aff><author-notes><corresp id="cor1"><label>*</label><italic>Corresponding author:</italic> Bahareh Amin. Cellular and Molecular Research Center, Department of Physiology and Pharmacology, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran. email: <email xlink:href="amin.bahareh@gmail.com">amin.bahareh@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2017</year></pub-date><volume>20</volume><issue>6</issue><fpage>708</fpage><lpage>714</lpage><history><date date-type="received"><day>29</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Iranian Journal of Basic Medical Sciences</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective(s):</title><p>The present study aimed to evaluate the putative antidepressant and anti-anxiety effects of the cinnamon essential oil when administered acute (for 3 doses) and sub-acute (for 14 days) to mice.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>In an acute experimental study, forced swim test (FST) was conducted to evaluate the antidepressant-like behavior of animals treated with the intraperitoneal (IP) essential oil of cinnamon in triple doses (0.5, 1, and 2 mg/kg). In a sub-acute study (14 days in 24-hr intervals) antidepressant-like effects of essential oil (0.5, 1, and 2 mg/kg) with the same route were assessed in FST and tail suspension test (TST). Anti-anxiety and motor activities were evaluated using elevated plus-maze (EPM) and open field tests, respectively. Determination of different constituents within the sample oil was via gas chromatography&#x02013;mass spectrometry (GC&#x02013;MS) analysis.</p></sec><sec id="st3"><title>Results:</title><p>Repetitive administration of cinnamon essential oil (0.5, 1, 2 mg/kg) during 14 days significantly decreased the time of immobility in both FST and TST as compared to the control group. Mice treated with oil at the dose of 2 mg/kg spent a longer time and had more entries into the open arms of EPM as compared with the vehicle-treated ones. According to GC-MS analysis, 46 chemical compounds were identified in the studied cinnamon essential oil with the main constituent being trans-cinnamaldehyde (87.32%).</p></sec><sec id="st4"><title>Conclusion:</title><p>Cinnamon essential oil might be used as an adjunctive therapy in improving symptoms of depressive and anxiety disorders. However, dose-response effects need further evaluation. Trans-cinnamaldehyde might be responsible for the beneficial effect observed.</p></sec></abstract><kwd-group><kwd>Cinnamon bark</kwd><kwd>Elevated plus maze</kwd><kwd>Essential oil</kwd><kwd>Forced swimming test</kwd><kwd>Tail suspension test</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Depression is a major chronic psychiatric dis-order affecting nearly 21% of the world population and imposes a substantial health burden on the society (<xref rid="ref1" ref-type="bibr">1</xref>). People with a depressed mood are characterized by despair, loss of interest in daily working and social relationship, sadness, anxiety, hopelessness, helplessness, and guilt (<xref rid="ref2" ref-type="bibr">2</xref>). There are three main kinds of classical antidepressants in clinical practice, including tricyclic antidepressants (amitriptyline, nortriptyline, and desipramine), selec-tive serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, citalopram, and monoamine oxidase inhibitors (MAOIs) including moclobemide and tranylcypromine. Although approved antidepre-ssant drugs are effective, a significant number of people do not efficiently respond. In addition, these drugs are accompanied with many adverse effects (<xref rid="ref3" ref-type="bibr">3</xref>, <xref rid="ref4" ref-type="bibr">4</xref>). Accordingly, there is a need for the development of new drugs with more efficacies and less adverse effects. Natural products displaying antidepressant effects are of great interest and may be important sources of new antidepressant drugs (<xref rid="ref5" ref-type="bibr">5</xref>, <xref rid="ref6" ref-type="bibr">6</xref>).</p><p>Cinnamon (sweet wood) the brown bark of <italic>Cinnamomum</italic>
<italic>verum</italic> (true cinnamon tree or Ceylon cinnamon tree), belonging to the Lauraceae family, is native to Southern India and Sri Lanka. Since ancient times cinnamon has been commonly used as a spice and flavoring material for desserts, candies, chocolate, etc.; it has a long history as a medicine, as well. Medieval physicians used cinnamon to treat a variety of disorders including headaches, neuralgia, gastritis, coughing, hoarseness, sore throats, etc. (<xref rid="ref7" ref-type="bibr">7</xref>). In many experimental as well as clinical studies, cinnamon has been demonstrated to possess anti-inflammatory (<xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref9" ref-type="bibr">9</xref>), anti-oxidant (<xref rid="ref10" ref-type="bibr">10</xref>), anti-diabetic (<xref rid="ref11" ref-type="bibr">11</xref>, <xref rid="ref12" ref-type="bibr">12</xref>) anti-microbial (<xref rid="ref13" ref-type="bibr">13</xref>), analgesic (<xref rid="ref14" ref-type="bibr">14</xref>) and wound-healing (<xref rid="ref15" ref-type="bibr">15</xref>) properties. Anticancer (<xref rid="ref16" ref-type="bibr">16</xref>), lipid-lowering (<xref rid="ref17" ref-type="bibr">17</xref>), and cardiovascular- disease protective effects of this compound have also been investigated (<xref rid="ref18" ref-type="bibr">18</xref>). In addition, cinnamon has shown promising effects against neurological disorders, such as Parkinson&#x02019;s and Alzheimer&#x02019;s diseases (<xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref20" ref-type="bibr">20</xref>).</p><p>The specific aim of this study was to examine whether the essential oil obtained from cinnamon bark has anti-anxiety and/or antidepressant-like properties in acute (triple doses) or sub-acute regimen (14 days), in behavioral models of anxiety and depression in mice.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Animals</title><p>Male albino mice (20&#x02013;30 g) obtained from the Animal House of Sabzevar University of medical Sciences, were used in this study. Food and water were provided <italic>ad libitum</italic> in colony rooms with 12/12 hr light/dark cycle at 22&#x000b1;2 &#x000b0;C. The procedures in this study were performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (<xref rid="ref21" ref-type="bibr">21</xref>) and approved by Sabzevar University of Medical Sciences (ethical no: ir.medsab.rec.1394.16).</p></sec><sec id="sec2-2"><title>Materials</title><p>Cinnamon volatile (essential) oil was extracted from cinnamon wood in our laboratory and administered intraperitoneally (0.5, 1, and 2 mg/kg) in acute treatment. Cinnamon was administered same as the previous protocol in the sub-acute administration for 14 days. Cinnamon was solved in normal saline + Tween 80 (1%). The solution was freshly prepared before administration. Fluoxetine (Dr. Abidi Pharm Co, Iran) and desipramine (Pars Daru Co, Iran) were used as positive control drugs in depressive behaviors. Diazepam (Darupakhsh Co. Iran) was used as a positive control drug in the elevated plus maze test. Dosage selection was based on previous studies (<xref rid="ref22" ref-type="bibr">22</xref>, <xref rid="ref23" ref-type="bibr">23</xref>).</p></sec><sec id="sec2-3"><title>Preparation of oil</title><p>Dried bark parts of cinnamon (50 g) were finely ground and subjected to a Clevenger-type apparatus for 4 hr to extract the oil by the hydrodistillation method. The total yield of volatile oil was 1% (W/W). The oil was dried over anhydrous sodium sulfate and stored at 4&#x000b0;C before analysis (<xref rid="ref24" ref-type="bibr">24</xref>).</p></sec><sec id="sec2-4"><title>Gas chromatography&#x02013;mass spectrometry (GC&#x02013;MS) analysis</title><p>The oil analysis was carried on a GC7890N AGILENT &#x00026; MS 5975 (EI mass detector), in the following conditions: chromatography was achieved using a (5%-phenyl)-methyl polysiloxane HP-5MS column (30 m &#x000d7; 0.25 mm, 0.25 mm film thickness) with a helium carrier gas, adjusted to a linear velocity of 1 ml/min. the column was with a 50:1 split ratio. The injector temperature was regulated at 260 &#x000b0;C. also, The column oven temperature was maintained at 60 &#x000b0;C for 4 min and programmed to 100 &#x000b0;C at 3 &#x000b0;C/min for 2 min and then to 250 &#x000b0;C at 6 &#x000b0;C/min for 6 min; electron energy at 70 eV. Positive ions were observed while the analyzer was scanned from mass 50 to 550. The Kovats indices were determined for all volatile constituents using a mixture of homologous series of n-alkanes C9&#x02013;C23 on HP-5MS column. The components were identified by comparison of their mass spectra with those of the NIST 5 mass spectra library. The Kovats indices were calculated using by following formula (<xref rid="ref25" ref-type="bibr">25</xref>).</p><p><inline-graphic xlink:href="IJBMS-20-708-g001.jpg"/></p><p>Where: I= Kovats retention index, tn=the number of carbon atoms in the smaller n-alkane, tN= the number of carbon atoms in the larger n-alkane, and tc= the retention time.</p></sec><sec id="sec2-5"><title>Behavioral study</title><sec id="sec3-1"><title>Acute treatment</title><p>In the acute dose study, groups were as follows:</p><p>Group I: Vehicle control group (normal saline plus Tween 80 (1%); Group II-IV: cinnamon essential oil (0.5, 1, and 2 mg/kg); Group V: Desipramine 10 mg/kg; Group VI: Fluoxetine 10 mg/kg.</p><p>All drugs were given intraperitoneally, 1, 8, and 24 hr before the test. In the acute study, antidepressant-like effects were assessed using the forced swim test (FST). Locomotor activity and anxiety-like behaviors were measured by the open field test and elevated plus maze, respectively.</p></sec><sec id="sec3-2"><title>Sub-acute treatment</title><p>In the sub-acute study, groups were as follows:</p><p>Group I: Vehicle control group (Tween 80+normal saline); Group II-IV: cinnamon essential oil (0.5, 1, and 2 mg/kg) for antidepressant activity; Group V-VII: cinnamon essential oil 0.5, 1, and 2 mg/kg for antianxiety activity; Group VIII: Desipramine 10 mg/kg; Group IX: Fluoxetine 10 mg/kg; Group X: Diazepam 2 mg/kg.</p><p>In this regimen, drugs were given once daily during a period of 14-day, through the same route as in the previous regimen. Antidepressant-like effects were evaluated in FST and tail suspension test (TST). Locomotor activity and anxiety-like behavior were measured using the open field test and elevated plus-maze, respectively.</p></sec><sec id="sec3-3"><title>Forced swim test</title><p>TFST is one of the most widely acceptable rodent behavioral models used for assessing depression and antidepressant-like efficacy of new drugs. One hour after the last treatment of acute study or 24 hr after tTST of sub-acute study, mice were individually placed in an inescapable transparent cylinder (15 cm in diameter), filled with 35 cm of room temperature water, such that the animals could not touch the bottom of the container with their hind paws or their tails. Immobility of animals was recorded during 6 min and the first 2 min was considered as trial (pre-test) (<xref rid="ref26" ref-type="bibr">26</xref>).</p></sec><sec id="sec3-4"><title>Tail suspension test</title><p>TST was performed one day before FST in the sub-acute study. In this test, the mice were suspended by their tails, using tape, from a wire at the height of 33 cm. In such a position the animal was not able to escape or hold onto nearby surfaces. The absence of initiated movements was defined as immobility and recorded during a short-time period of 6 min and the first 2 min was considered as trial (pre-test). Mice were returned to the box after each animal was tested (<xref rid="ref27" ref-type="bibr">27</xref>).</p></sec><sec id="sec3-5"><title>Open field test</title><p>A wooden (30&#x02286;30 cm) box with sidewalls of 40 cm was used to measure locomotor/exploratory activity of animals in a quiet environment. After passing 45 min of the last treatment of the acute study or after the 14th day of sub-acute study, animals were placed in the center of box and number of squares crossed with four paws of the animal was recorded. Each trial lasted 5 min (<xref rid="ref28" ref-type="bibr">28</xref>).</p></sec><sec id="sec3-6"><title>Elevated plus maze</title><p>For conducting this test, different groups of animals received normal saline or essential oil for 14 days, and were individually placed in the center of a wooden cross elevated 40 cm above the floor. This apparatus consisted of two open (30&#x02286;5 &#x02286;0.25 cm) and two closed arms (30&#x02286;5&#x02286;40 cm) as described previously (<xref rid="ref29" ref-type="bibr">29</xref>). At the time of the experiment, each animal was placed in the center of apparatus, facing one of the open arms. Anxiety was evaluated during 5 min by recording the entries to open arms/total entries and the time spent in the open arms/time spent in all arms of the apparatus.</p><p>For all three tests, after ending each trial session, fecal boli and urine were removed and surfaces were cleaned with 70% ethanol to start the next session.</p></sec></sec><sec id="sec2-6"><title>Statistical analysis</title><p>SThe SPSS software package (version 17; Chicago, IL, USA) was used for statistical analysis. All data were expressed as the mean&#x000b1;standard error of the mean (SEM). A one-way ANOVA test at <italic>P</italic>&#x0003c;0.05 was considered significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><sec id="sec2-7"><title>Chemical composition of the essential oil</title><p>The hydrodistillation of the bark of <italic>C. verum</italic> gave a yellowish essential oil with 1% yield. Among the 15 components that were identified, the main component was trans-cinnamaldehyde (87.32%). The other considerable constituents were beta-tumerone (3.31%), <italic>O-</italic> cinnamaldehyde diethyl acetal (2.34%), and o-Methoxycinnamaldehyde (1.88%) (<xref ref-type="table" rid="T1">Table 1</xref>). In this study, the oil consisted mainly of phenolic compounds (96.7%), sesquiterpene hydrocarbons (2.5%), and small amounts of monoterpene hydrocarbons (0.35%) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Chemical composition of cinnamon in the essential oil of cinnamon bark</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">No.</th><th align="center" rowspan="1" colspan="1">Compound</th><th align="center" rowspan="1" colspan="1">Retention time</th><th align="center" rowspan="1" colspan="1">Concentration (%)</th><th align="center" rowspan="1" colspan="1">KI (Kovats retention index)</th><th align="center" rowspan="1" colspan="1">Class</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Benzenepropanal</td><td align="center" rowspan="1" colspan="1">15.54</td><td align="center" rowspan="1" colspan="1">0.19</td><td align="center" rowspan="1" colspan="1">1151</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Cis-cinnamaldehyde</td><td align="center" rowspan="1" colspan="1">18.08</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">1206</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">2-Methyl-3-phenyl-propanal</td><td align="center" rowspan="1" colspan="1">19.04</td><td align="center" rowspan="1" colspan="1">0.30</td><td align="center" rowspan="1" colspan="1">1225</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Trans-cinnamaldehyde</td><td align="center" rowspan="1" colspan="1">21.30</td><td align="center" rowspan="1" colspan="1">87.32</td><td align="center" rowspan="1" colspan="1">1270</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Cinnamaldehyde diethyl acetal</td><td align="center" rowspan="1" colspan="1">26.39</td><td align="center" rowspan="1" colspan="1">2.34</td><td align="center" rowspan="1" colspan="1">1385</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Calamenene</td><td align="center" rowspan="1" colspan="1">30.73</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">1505</td><td align="center" rowspan="1" colspan="1">MH</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">o-Methoxycinnamaldehyde</td><td align="center" rowspan="1" colspan="1">31.08</td><td align="center" rowspan="1" colspan="1">1.88</td><td align="center" rowspan="1" colspan="1">1516</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Alpha-longyi pinene</td><td align="center" rowspan="1" colspan="1">33.60</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">1596</td><td align="center" rowspan="1" colspan="1">SH</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">&#x003b4;-Cadinene</td><td align="center" rowspan="1" colspan="1">34.02</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">1610</td><td align="center" rowspan="1" colspan="1">SH</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">t-cadinol</td><td align="center" rowspan="1" colspan="1">34.46</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">1625</td><td align="center" rowspan="1" colspan="1">SH</td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">Copaene</td><td align="center" rowspan="1" colspan="1">34.59</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">1629</td><td align="center" rowspan="1" colspan="1">SH</td></tr><tr><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">Alpha-cadinol</td><td align="center" rowspan="1" colspan="1">34.83</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">1638</td><td align="center" rowspan="1" colspan="1">SH</td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">Beta-tumerone</td><td align="center" rowspan="1" colspan="1">35.17</td><td align="center" rowspan="1" colspan="1">3.31</td><td align="center" rowspan="1" colspan="1">1649</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">Alpha-bisabolol</td><td align="center" rowspan="1" colspan="1">35.76</td><td align="center" rowspan="1" colspan="1">0.34</td><td align="center" rowspan="1" colspan="1">1670</td><td align="center" rowspan="1" colspan="1">SH</td></tr><tr><td align="center" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">Alpha-tumerone</td><td align="center" rowspan="1" colspan="1">36.20</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">1685</td><td align="center" rowspan="1" colspan="1">PC</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total identified</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">99.55</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Gas chromatography&#x02013;mass spectrometry (GC&#x02013;MS) fingerprint of cinnamon essential oil</p></caption><graphic xlink:href="IJBMS-20-708-g002"/></fig></sec><sec id="sec2-8"><title>Effect of cinnamon essential oil on the forced swimming test</title><p>There were no differences among groups in the acute study when essential oil was administered three times as mentioned in the methods section (data not shown).</p><p>Time spent immobile with 0.5, 1, and 2 mg/kg of cinnamon essential oil for 14 days was significantly less than that in the vehicle-treated mice (<xref ref-type="fig" rid="F2">Figure 2A</xref>; <italic>P</italic>&#x0003c;0.001). Desipramine and fluoxetine (10 mg/kg) as the reference drugs decreased immobility as compared with the vehicle-treated group during 5 min observation.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>A: Time (sec) spent immobile in the forced swimming test (FST) (mean&#x000b1;SEM) and <bold>B:</bold> in the tail suspension test (mean&#x000b1;SEM) in mice during a 6-2=4 min test. Mice were injected with vehicle control, essential oil (0.5, 1, and 2 mg/kg, IP), fluoxetine, and desipramine (10 mg/kg, IP), for a 14 day treatment. *** <italic>P</italic>&#x0003c;0.001 is significantly different from the control group</p></caption><graphic xlink:href="IJBMS-20-708-g003"/></fig></sec><sec id="sec2-9"><title>Effect of cinnamon essential oil in the tail suspension test</title><p>The data of behavioral observation during the suspension of the tail from wire is presented in <xref ref-type="fig" rid="F2">Figure 2B</xref>. Mice treated with essential oil (0.5, 1, and 2 mg/kg) spent significantly less time as compared with those who received vehicle (<italic>P</italic>&#x0003c;0.001). Time spent immobile was significantly decreased in desipramine and fluoxetine (10 mg/kg, as the reference drugs) treated groups (<italic>P</italic>&#x0003c;0.001).</p></sec><sec id="sec2-10"><title>Effect of cinnamon essential oil in the elevated plus maze test</title><p>As indicated in Figures <xref ref-type="fig" rid="F3">3A</xref> and <xref ref-type="fig" rid="F3">3B</xref>, one-way ANOVA of the data obtained from the cinnamon essential oil at the dose of 2 mg/kg showed a significant increase in the percent of time spent in the open arms/time spent in all arms or the percent of entries to open arm/total entries in mice placed at the center of EPM, in comparison with the vehicle-treated control group (<italic>P</italic>&#x0003c;0.05). The diazepam-treated (2 mg/kg, IP) positive control group showed significantly more time spent in the open arms/ time spent in all arms (<italic>P</italic>&#x0003c;0.05), and more entries to open arms/ all arms (<italic>P</italic>&#x0003c;0.001), compared with the vehicle-treated control group.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>A: Percent of time spent in the open arms to time spent in all arms and B: Percent of entries to open arm to total entries in mice placed at the center of the plus-maze and given a 5-min test. Mice were injected with vehicle control, essential oil (0.5, 1, and 2 mg/kg, IP), diazepam (2 mg/kg, IP), for 14 days. * <italic>P</italic>&#x0003c;0.05, *** <italic>P</italic>&#x0003c;0.001 is significantly different from the control group</p></caption><graphic xlink:href="IJBMS-20-708-g004"/></fig></sec><sec id="sec2-11"><title>Effect of cinnamon essential oil in the open field test</title><p>As shown in <xref ref-type="fig" rid="F4">Figure 4</xref>, the total squares crossed by animals treated with cinnamon or fluoxetine/ desipramine was not different from those receiving the vehicle during a 5-min observation period in the open field test. There was a reduction in the number of squares crossed by diazepam-treated animals, although it did not reach a significant difference with the control animals.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Number of lines crossed by the four paws of the animal (mean&#x000b1;SEM) at the open field apparatus during a 5-min test. Mice were injected with vehicle control, essential oil (0.5, 1, and 2 mg/kg, IP), diazepam (1 or 2 mg/kg, IP), during a 14-day treatment</p></caption><graphic xlink:href="IJBMS-20-708-g005"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>Our results in this study demonstrated anti-depressant-like activity of cinnamon in mice treated with the essential oil of cinnamon (0.5, 1, 2 mg/kg) with shorter duration of immobility in both FST and TST as compared to the control animals, during a 14-day regimen. These tests frequently used in animal studies, force animals to combat two different stressful situations (floating or hemodynamic stress) and show a difference in some cases (<xref rid="ref27" ref-type="bibr">27</xref>). Although oil at the three applied doses showed antidepressant-like activity data of dose response was not the same as in FST, it showed a U-shape pattern of activity, while in TST it had a linear relationship. The same results were reported in the Bai <italic>et al</italic>. study on the antidepressant effect of imipramine (<xref rid="ref30" ref-type="bibr">30</xref>). It seems that involved neurochemical pathways of these famous behavioral tests are not the same.</p><p>In the EPM test, based on natural avoidance of mice for open area, animals spent more time in the closed area. However, animals receiving cinnamon 2 mg/kg for 14 days exhibited an anti-anxiety like effect by spending more time and more entries to the open arm of EPM.</p><p>Locomotor activities of animals decreased but had no significant difference in relation to the control group in the open field test. Consequently, cinnamon seems to have no effect on overall locomotion compared with vehicle-treated controls. Reference drug, diazepam belonging to benzodiazepines has been used for anxiety disorders; however, sedative, amnesic and dependence-inducing characteristics in repeated administrations limit its safe prescription (<xref rid="ref31" ref-type="bibr">31</xref>).</p><p>Today, the role of neuroinflammation and oxidative stress has been highlighted in the pathogenesis of psychologic disorders such as anxiety and depressive disorders (<xref rid="ref32" ref-type="bibr">32</xref>, <xref rid="ref33" ref-type="bibr">33</xref>).</p><p>Trans-cinnamaldehyde, an organic compound that gives cinnamon its flavor and odor is responsible for many biological activities observed with cinnamon. It has been reported that cinnamaldehyde constitutes 65 to 80% of cinnamon bark (<xref rid="ref34" ref-type="bibr">34</xref>, <xref rid="ref35" ref-type="bibr">35</xref>). GC-MS analysis indicated that polyphenols contents were higher than other constituents in the sample essential oil of cinnamon and main polyphenolic compounds measured were trans-cinnamaldehyde, turmerone, and <italic>O-</italic> cinnamaldehyde diethyl acetal (87.32%, 3.31%, and 2.34%, respectively). Anti-inflammatory effect of turmerone has been reported to be via microglia activation inhibition (<xref rid="ref36" ref-type="bibr">36</xref>). Trans-cinnamaldehyde represented neuroprotective activity in a model of ischemia/reperfusion (I/R)-induced brain injury in rats via suppressing protein levels of inflammatory mediators such as inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), and nuclear factor kappa B (NF-&#x003ba;B) signaling pathway (<xref rid="ref37" ref-type="bibr">37</xref>). In an investigation by Sahib, antidiabetic activity of cinnamon in poorly controlled diabetic patients was associated with increased serum levels of antioxidants such as glutathione, superoxide dismutase, and decreased levels of malondialdehyde as a marker of lipid peroxidation in the cinnamon treated group (<xref rid="ref11" ref-type="bibr">11</xref>).</p><p>Consequently, one of the potentially involved pathways in antidepressant and antianxiety activity might be antioxidant and anti-inflammatory properties of cinnamon, however, it needs further experimental studies to elucidate this hypothesis.</p><p>Another mechanism playing an important role in the molecular neurobiology of depressive disorder is decreased monoamine function in the brain, known as monoamine hypothesis (<xref rid="ref38" ref-type="bibr">38</xref>). Intravenous cinnamalde-</p><p>hyde increased adrenaline secretion via activating thermosensitive transient receptor potential (TRP) channels, mainly expressed in the sensory neurons, and induced secretion of adrenaline via the CNS (<xref rid="ref39" ref-type="bibr">39</xref>).</p><p>An important factor in the pathogenesis of major depression is the reduction of neurotrophic factors such as the brain-derived neurotrophic factor (<xref rid="ref40" ref-type="bibr">40</xref>). Cinnamon and its metabolite sodium benzoate have been shown to increase the level of neurotrophic factors such as BDNF, which may be of benefit for the treatment of depressive disorders (<xref rid="ref41" ref-type="bibr">41</xref>).</p><p>Although cinnamon is a safe drug, a report of intraoral allergy to cinnamic aldehyde has been reported (<xref rid="ref40" ref-type="bibr">40</xref>, <xref rid="ref41" ref-type="bibr">41</xref>). As a result, it should be considered with caution in patients with increased sensitivity.</p><p>According to a meta-analysis study, combination therapy has shown better outcomes in the treatment of depressed and anxious patients (<xref rid="ref42" ref-type="bibr">42</xref>), adding cinnamon to conventional drugs would be of worth in future experimental and clinical studies for add-on or single therapy of depressed patients.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>Cinnamon essential oil could have beneficial effects in improving depressive and anxiety disorders and might be used as an adjunctive therapy to conventional drugs. However, dose-response effects need further evaluation. Trans-cinnamaldehyde might be responsible for the beneficial effect observed with the essential oil of cinnamon.</p></sec></body><back><ack><title>Acknowledgment</title><p>We are grateful for the financial support of Vice-chancellor for Research and Technology, Sabzevar University of Medical Sciences, Sabzever, Iran.</p></ack><sec id="sec1-6"><title>Conflicts of interest</title><p>There are no conflicts of interest in this study.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maletic</surname><given-names>V</given-names></name><name><surname>Robinson</surname><given-names>M</given-names></name><name><surname>Oakes</surname><given-names>T</given-names></name><name><surname>Iyengar</surname><given-names>S</given-names></name><name><surname>Ball</surname><given-names>SG</given-names></name><name><surname>Russell</surname><given-names>J</given-names></name></person-group><article-title>Neurobiology of depression: an integrated view of key findings</article-title><source>Int J Clin Pract</source><year>2007</year><volume>61</volume><fpage>2030</fpage><lpage>2040</lpage><pub-id pub-id-type="pmid">17944926</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>JJ</given-names></name><name><surname>Silber</surname><given-names>T</given-names></name><name><surname>Bruno</surname><given-names>D</given-names></name><name><surname>Galatzer-Levy</surname><given-names>IR</given-names></name><name><surname>Pomara</surname><given-names>N</given-names></name><name><surname>Marmar</surname><given-names>CR</given-names></name></person-group><article-title>Is there progress? An overview of selecting biomarker candidates for major depressive disorder</article-title><source>Front Psychiatr</source><year>2016</year><volume>7</volume><fpage>72</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bschor</surname><given-names>T</given-names></name><name><surname>Kilarski</surname><given-names>LL</given-names></name></person-group><article-title>Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults</article-title><source>Expert Rev Neurother</source><year>2016</year><volume>16</volume><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">26891111</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gartlehner</surname><given-names>G</given-names></name><name><surname>Gaynes</surname><given-names>BN</given-names></name><name><surname>Amick</surname><given-names>HR</given-names></name><name><surname>Asher</surname><given-names>G</given-names></name><name><surname>Morgan</surname><given-names>LC</given-names></name><name><surname>Coker-Schwimmer</surname><given-names>E</given-names></name><etal/></person-group><source>Nonpharmaco-logical versus pharmacological treatments for adult patients with major depressive disorder</source><year>2015</year><publisher-loc>Rockville (MD)</publisher-loc><publisher-name>Agency for Healthcare Research and Quality (US)</publisher-name></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajemiroye</surname><given-names>JO</given-names></name><name><surname>da Silva</surname><given-names>DM</given-names></name><name><surname>de Oliveira</surname><given-names>DR</given-names></name><name><surname>Costa</surname><given-names>EA</given-names></name></person-group><article-title>Treatment of anxiety and depression: medicinal plants in retrospect</article-title><source>Fundam Clin Pharmacol</source><year>2016</year><volume>30</volume><fpage>198</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">26851117</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardebili</surname><given-names>Dorri S</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name><name><surname>Abnous</surname><given-names>K</given-names></name><name><surname>Vahdati</surname><given-names>Hasani F</given-names></name><name><surname>Yazdian</surname><given-names>Robati R</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name></person-group><article-title>Involvement of brain-derived neurotrophic factor (BDNF) on malathion induced depressive-like behavior in subacute exposure and protective effects of crocin</article-title><source>Iran J Basic Med Sci</source><year>2015</year><volume>18</volume><fpage>958</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">26730329</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharat B</surname><given-names>Aggarwal</given-names></name><name><surname>Kunnumakkara</surname><given-names>AB</given-names></name></person-group><article-title>Molecular targets and therapeutic uses of spices. Modern uses for ancient medicine</article-title><source>Mol Nutr Food Res</source><year>2013</year><volume>57</volume><fpage>1510</fpage><lpage>1528</lpage><pub-id pub-id-type="pmid">22887802</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Son</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Yoo</surname><given-names>HS</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><etal/></person-group><article-title>Inhibitory effect of 2&#x02032;-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-&#x003ba;B activation in RAW 264.7 cells</article-title><source>Biochem Pharmacol</source><year>2005</year><volume>69</volume><fpage>791</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">15710356</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>A</given-names></name><name><surname>Nunes</surname><given-names>C</given-names></name><name><surname>Escudier</surname><given-names>M</given-names></name><name><surname>Lomer</surname><given-names>MC</given-names></name><name><surname>Barnard</surname><given-names>K</given-names></name><name><surname>Shirlaw</surname><given-names>P</given-names></name><etal/></person-group><article-title>Improvement in orofacial granulomatosis on a cinnamon-and benzoate-free diet</article-title><source>Inflamm Bowel Dis</source><year>2006</year><volume>12</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">16775496</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molania</surname><given-names>T</given-names></name><name><surname>Moghadamnia</surname><given-names>AA</given-names></name><name><surname>Pouramir</surname><given-names>M</given-names></name><name><surname>Aghel</surname><given-names>S</given-names></name><name><surname>Moslemi</surname><given-names>D</given-names></name><name><surname>Ghassemi</surname><given-names>L</given-names></name><etal/></person-group><article-title>The effect of cinnamaldehyde on mucositis and salivary antioxidant capacity in gamma-irradiated rats (a preliminary study)</article-title><source>Daru</source><year>2012</year><volume>20</volume><fpage>89</fpage><pub-id pub-id-type="pmid">23351595</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahib</surname><given-names>AS</given-names></name></person-group><article-title>Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: A randomized, placebo-controlled clinical trial</article-title><source>J Intercult Ethnopharmacol</source><year>2016</year><volume>5</volume><fpage>108</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">27104030</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blevins</surname><given-names>SM</given-names></name><name><surname>Leyva</surname><given-names>MJ</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Scofield</surname><given-names>RH</given-names></name><name><surname>Aston</surname><given-names>CE</given-names></name></person-group><article-title>Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>2236</fpage><lpage>2237</lpage><pub-id pub-id-type="pmid">17563345</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabavi</surname><given-names>SF</given-names></name><name><surname>Di Lorenzo</surname><given-names>A</given-names></name><name><surname>Izadi</surname><given-names>M</given-names></name><name><surname>Sobarzo-Sanchez</surname><given-names>E</given-names></name><name><surname>Daglia</surname><given-names>M</given-names></name><name><surname>Nabavi</surname><given-names>SM</given-names></name></person-group><article-title>Antibacterial effects of cinnamon: From farm to food, cosmetic and pharmaceutical industries</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>7729</fpage><lpage>7748</lpage><pub-id pub-id-type="pmid">26378575</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>ZP</given-names></name><name><surname>Zhang</surname><given-names>MF</given-names></name><name><surname>Shen</surname><given-names>YQ</given-names></name><name><surname>Chen</surname><given-names>GJ</given-names></name></person-group><article-title>Pharmacological study on spleen-stomach warming and analgesic action of <italic>Cinnamomum cassia</italic> Presl</article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>1993</year><volume>18</volume><fpage>553</fpage><lpage>7</lpage><comment>14-15</comment><pub-id pub-id-type="pmid">8011112</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamath</surname><given-names>JV</given-names></name><name><surname>Rana</surname><given-names>AC</given-names></name><name><surname>Chowdhury</surname><given-names>AR</given-names></name></person-group><article-title>Pro-healing effect of <italic>Cinnamomum zeylanicum</italic> bark</article-title><source>Phytother Res</source><year>2003</year><volume>17</volume><fpage>970</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">13680838</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>TW</given-names></name><name><surname>Tsai</surname><given-names>KD</given-names></name><name><surname>Yang</surname><given-names>SM</given-names></name><name><surname>Wong</surname><given-names>HY</given-names></name><name><surname>Liu</surname><given-names>YH</given-names></name><name><surname>Cherng</surname><given-names>J</given-names></name><etal/></person-group><article-title>Discovery of a novel anti-cancer agent targeting both topoisomerase I &#x00026; II as well as telomerase activities in human lung adenocarcinoma A549 cells <italic>in vitro</italic> and <italic>in vivo: Cinnamomum verum</italic> component cuminaldehyde</article-title><source>Curr Cancer Drug Targets</source><year>2016</year><volume>16</volume><fpage>796</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">27113744</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Hyun</surname><given-names>SH</given-names></name><name><surname>Choung</surname><given-names>SY</given-names></name></person-group><article-title>Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice</article-title><source>J Ethnopharmacol</source><year>2006</year><volume>104</volume><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">16213119</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyadjeu</surname><given-names>P</given-names></name><name><surname>Nguelefack-Mbuyo</surname><given-names>EP</given-names></name><name><surname>Atsamo</surname><given-names>AD</given-names></name><name><surname>Nguelefack</surname><given-names>TB</given-names></name><name><surname>Dongmo</surname><given-names>AB</given-names></name><name><surname>Kamanyi</surname><given-names>A</given-names></name></person-group><article-title>Acute and chronic antihypertensive effects of <italic>Cinnamomum zeylanicum</italic> stem bark methanol extract in L-NAME-induced hypertensive rats</article-title><source>BMC Complement Altern Med</source><year>2013</year><volume>13</volume><fpage>27</fpage><pub-id pub-id-type="pmid">23368533</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frydman-Marom</surname><given-names>A</given-names></name><name><surname>Levin</surname><given-names>A</given-names></name><name><surname>Farfara</surname><given-names>D</given-names></name><name><surname>Benromano</surname><given-names>T</given-names></name><name><surname>Scherzer-Attali</surname><given-names>R</given-names></name><name><surname>Peled</surname><given-names>S</given-names></name><etal/></person-group><article-title>Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer&#x02019;s disease animal models</article-title><source>PloS One</source><year>2011</year><volume>6</volume><fpage>e16564</fpage><pub-id pub-id-type="pmid">21305046</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khasnavis</surname><given-names>S</given-names></name><name><surname>Pahan</surname><given-names>K</given-names></name></person-group><article-title>Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson&#x02019;s disease</article-title><source>J Neuroimmune Pharmacol</source><year>2014</year><volume>9</volume><fpage>569</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">24946862</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>National Research</surname><given-names>Council</given-names></name></person-group><source>Guide for the care and use of laboratory animals</source><year>1996</year><publisher-loc>Washington, D. C</publisher-loc><publisher-name>National Academy Press</publisher-name></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dashti-R</surname><given-names>MH</given-names></name><name><surname>Qane</surname><given-names>MD</given-names></name><name><surname>Shefaie</surname><given-names>F</given-names></name><name><surname>Nazemian Yazdu</surname><given-names>M</given-names></name><name><surname>Bagheri</surname><given-names>SM</given-names></name></person-group><article-title>Comparative effect of cinnamon essential oil, diclofenac and morphine on acute and chronic pain in mice</article-title><source>Int J Med Lab</source><year>2016</year><volume>3</volume><fpage>92</fpage><lpage>103</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>B</given-names></name><name><surname>Nakhsaz</surname><given-names>A</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Evaluation of the antidepressant-like effects of acute and sub-acute administration of crocin and crocetin in mice</article-title><source>Avicenna J Phytomed</source><year>2015</year><volume>54</volume><fpage>458</fpage><lpage>468</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iravani</surname><given-names>S</given-names></name><name><surname>Zolfaghari</surname><given-names>B</given-names></name></person-group><article-title>Phytochemical analysis of <italic>Pinus eldarica</italic> bark</article-title><source>Res Pharm Sci</source><year>2014</year><volume>9</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">25657795</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>M</given-names></name><name><surname>Kozukue</surname><given-names>N</given-names></name><name><surname>Harden</surname><given-names>LA</given-names></name></person-group><article-title>Cinnamaldehyde content in foods determined by gas chromatography-mass spectrometry</article-title><source>J Agric Food Chem</source><year>2000</year><volume>48</volume><fpage>5702</fpage><lpage>5709</lpage><pub-id pub-id-type="pmid">11087542</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borsini</surname><given-names>F</given-names></name><name><surname>Meli</surname><given-names>A</given-names></name></person-group><article-title>Is the forced swimming test a suitable model for revealing antidepressant activity?</article-title><source>Psychopharmacology</source><year>1988</year><volume>94</volume><fpage>147</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">3127840</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Mombereau</surname><given-names>C</given-names></name><name><surname>Vassout</surname><given-names>A</given-names></name></person-group><article-title>The tail suspension test as a model for assessing antidepre-ssant activity: review of pharmacological and genetic studies in mice</article-title><source>Neurosci Biobehav Rev</source><year>2005</year><volume>29</volume><fpage>571</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">15890404</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegmann</surname><given-names>JP</given-names></name><name><surname>DeFries</surname><given-names>JC</given-names></name></person-group><article-title>Open-field behavior in mice: Genetic analysis of repeated measures</article-title><source>Psychonomic Sci</source><year>1968</year><volume>13</volume><fpage>27</fpage><lpage>28</lpage></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellow</surname><given-names>S</given-names></name><name><surname>File</surname><given-names>SE</given-names></name></person-group><article-title>Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat</article-title><source>Pharmacol Biochem Behav</source><year>1986</year><volume>24</volume><fpage>525</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">2871560</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Clay</surname><given-names>M</given-names></name><name><surname>Lindstrom</surname><given-names>T</given-names></name><name><surname>Skolnick</surname><given-names>P</given-names></name></person-group><article-title>Intra- and interstrain differences in models of &#x0201c;behavioral despair&#x0201d;. Pharmacol Biochem Behav</article-title><year>2001</year><volume>70</volume><fpage>187</fpage><lpage>192</lpage></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzun</surname><given-names>S</given-names></name><name><surname>Kozumplik</surname><given-names>O</given-names></name><name><surname>Jakovljevic</surname><given-names>M</given-names></name><name><surname>Sedic</surname><given-names>B</given-names></name></person-group><article-title>Side effects of treatment with benzodiazepines</article-title><source>Psychiatria Danubina</source><year>2010</year><volume>22</volume><fpage>90</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">20305598</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawdin</surname><given-names>BJ</given-names></name><name><surname>Mellon</surname><given-names>SH</given-names></name><name><surname>Dhabhar</surname><given-names>FS</given-names></name><name><surname>Epel</surname><given-names>ES</given-names></name><name><surname>Puterman</surname><given-names>E</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dysregulated relationship of inflammation and oxidative stress in major depression</article-title><source>Brain Behav Immun</source><year>2013</year><volume>31</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">23201587</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salim</surname><given-names>S</given-names></name></person-group><article-title>Oxidative stress and psychological dis-orders</article-title><source>Curr Neuropharmacol</source><year>2014</year><volume>12</volume><fpage>140</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">24669208</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaprakasha</surname><given-names>GK</given-names></name><name><surname>Rao</surname><given-names>LJ</given-names></name><name><surname>Sakariah</surname><given-names>KK</given-names></name></person-group><article-title>Chemical composition of volatile oil from <italic>Cinnamomum zeylanicum</italic> buds</article-title><source>Z Naturforsch C</source><year>2002</year><volume>57</volume><fpage>990</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">12562082</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Broadhurst</surname><given-names>CL</given-names></name><name><surname>Polansky</surname><given-names>MM</given-names></name><name><surname>Schmidt</surname><given-names>WF</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Flanagan</surname><given-names>VP</given-names></name><etal/></person-group><article-title>Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity</article-title><source>J Agric Food Chem</source><year>2004</year><volume>52</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">14709014</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>S-J</given-names></name></person-group><article-title>Aromatic-turmerone&#x02019;s anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling</article-title><source>Neurochem Int</source><year>2012</year><volume>61</volume><fpage>767</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">22766494</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YF</given-names></name><name><surname>Wang</surname><given-names>YW</given-names></name><name><surname>Huang</surname><given-names>WS</given-names></name><name><surname>Lee</surname><given-names>MM</given-names></name><name><surname>Wood</surname><given-names>WG</given-names></name><name><surname>Leung</surname><given-names>YM</given-names></name><etal/></person-group><article-title>Trans-cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of iNOS, COX-2 expression and NFkappa-B signaling pathway</article-title><source>Neuromol Med</source><year>2016</year><volume>18</volume><fpage>322</fpage><lpage>333</lpage></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Monroe</surname><given-names>SM</given-names></name><name><surname>Slavish</surname><given-names>GM</given-names></name><name><surname>Georgiades</surname><given-names>K</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Hammen</surname><given-names>CL</given-names></name><name><surname>Gotlib</surname><given-names>IH</given-names></name></person-group><source>The social environment and life stress in depression</source><year>2009</year><edition>2nd ed</edition><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>Y</given-names></name><name><surname>Tanabe</surname><given-names>M</given-names></name><name><surname>Kobata</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name></person-group><article-title>TRPA1 agonists-allyl isothiocyanate and cinnamaldehyde-induce adrenaline secretion</article-title><source>Biosci Biotechnol Biochem</source><year>2008</year><volume>72</volume><fpage>2608</fpage><lpage>2614</lpage><pub-id pub-id-type="pmid">18838811</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorri</surname><given-names>SA</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name><name><surname>Abnous</surname><given-names>K</given-names></name><name><surname>Hasani</surname><given-names>FV</given-names></name><name><surname>Robati</surname><given-names>RY</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name></person-group><article-title>Involvement of brain-derived neurotrophic factor (BDNF) on malathion induced depressive-like behavior in subacute exposure and protective effects of crocin</article-title><source>Iran J Basic Med Sci</source><year>2015</year><volume>18</volume><fpage>958</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">26730329</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jana</surname><given-names>A</given-names></name><name><surname>Modi</surname><given-names>KK</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>JA</given-names></name><name><surname>van</surname><given-names>Breemen RB</given-names></name><name><surname>Pahan</surname><given-names>K</given-names></name></person-group><article-title>Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: thera-peutic implications for neurodegenerative disorders</article-title><source>J Neuroimmune Pharmacol</source><year>2013</year><volume>8</volume><fpage>739</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">23475543</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaac-Renton</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>MK</given-names></name><name><surname>Parsons</surname><given-names>LM</given-names></name></person-group><article-title>Cinnamon spice and everything not nice: many features of intraoral allergy to cinnamic aldehyde</article-title><source>Dermatitis</source><year>2015</year><volume>26</volume><fpage>116</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">25984687</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>Z</given-names></name><name><surname>Piracha</surname><given-names>F</given-names></name><name><surname>Anderson</surname><given-names>L</given-names></name><name><surname>Mazzola</surname><given-names>N</given-names></name></person-group><article-title>Supplements for diabetes mellitus: A review of the literature</article-title><source>J Pharm Pract</source><year>2016</year><comment>(in press)</comment></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karyotaki</surname><given-names>E</given-names></name><name><surname>Smit</surname><given-names>Y</given-names></name><name><surname>Holdt</surname><given-names>Henningsen K</given-names></name><name><surname>Huibers</surname><given-names>MJ</given-names></name><name><surname>Robays</surname><given-names>J</given-names></name><name><surname>de</surname><given-names>Beurs D</given-names></name><etal/></person-group><article-title>Combining pharmacotherapy and psychotherapy or monotherapy for major depre-ssion? A meta-analysis on the long-term effects</article-title><source>J Affect Disord</source><year>2016</year><volume>194</volume><fpage>144</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">26826534</pub-id></element-citation></ref></ref-list></back></article>